Assessment of a hydroalcoholic surfactant solution as a medium for the dissolution testing of phenytoin

International Journal of Pharmaceutics

Volumn 140, Issue 1, 1996, Pages 25-32

  Darwish, I A ^a   El Massik, M A ^a   Hassan, E E ^a   El Khordagui, L K ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Central composite design; Dissolution; Hydroalcoholic surfactant solutions; Phenytoin

Indexed keywords

ALCOHOL; PHENYTOIN; POLYSORBATE 80; SURFACTANT;

ARTICLE; DISSOLUTION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0029844686     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04567-X     Document Type: Article

References (29)

1. Abdallah, O.Y., Ghaly, G.M., El-Khordagui, L.K., Naggar, V.F. and Khalil, S.A., A study of the in-vitro availability of phenytoin from solid dosage forms marketed in Egypt. Alex. J. Pharm. Sci., 3 (1989) 151-155.
2. Ari-Ulubelen, A., Akbuga, J., Bayraktar-Alpmen, G. and Gülhan, S., Effect of formulation factors on the in-vitro dissolution characteristics of phenytion sodium capsules. Pharm. Ind., 48 (1986) 393-395.
3. Bastami, S.M. and Groves, M.J., Some factors influencing the in-vitro release of phenytion from formulations. Int. J. Pharm., 1 (1978) 151-164,
4. Bayne, C.K. and Rubin, I.B., Practical experimental designs and optimization methods for chemists, VCH Publishers, Beach Florida, 1986, pp. 150-152.
5. Brandau, R. and Wehnert, H.V., Dissolution rates and bioavailabiliy of phenytoin preparations. Arzneim-Forsch. Drug Res., 29 (1979) 552-555.
6. Collett, J.H. and Tobin, E.A., Relationships between poloxamer structure and the solubilization of some para-substituted acetanilides. J. Pharm. Pharmacol., 31 (1979) 174-177.
7. Corrigan, O.I., Co-solvent systems in dissolution testing: Theoretical considerations. Drug Dev. Ind. Pharm., 17 (1991) 695-708.
8. Dodge, A. and Gould, P.I., Dissolution of chlorpropamide tablets in a methanol-water binary solvent system. Drug Dev. Ind. Pharm., 13 (1987) 1817-1826.
9. El-Khordagui, L.K., A study of hydrotrope-cosolvent solubilised systems. Alex. J. Pharm. Sci., 5 (1991) 103-108.
10. El-Massik, M.A., Darwish, I.A., Hassan, E.E. and El-Khordagui, L.K., Development of a dissolution medium for glibenclamide. Int. Conf Pharm. Sci. Tech., Alexandria, Egypt, March 22-25, 1995.
11. Gupta, V.Das and Gupta, A., Stability of some oral solid drug products when stored in counting machine. Am. J. Hosp. Pharm., 36 (1979) 1539-1541.
12. Heng, W.S. and Wan, L.S.C., Surfactant effect on the dissolution of sulfanilamide granules. J. Pharm. Sci., 74 (1985) 269-272.
13. Itai, S., Nemoto, M., Kouchiwa, S., Murayama, H. and Nagai, T., Influence of wetting factors on the dissolution behaviour of flufenamic acid. Chem. Pharm. Bull., 33 (1985) 5464-5473.
14. Mukerjee, P., Solubilization of benzoic acid derivatives by non-ionic surfactants. Location of solubilizates in hydrocarbon core of micelles and poly (oxyethylene) mantle. J. Pharm. Sci., 60 (1971) 1528-1531.
15. Murthy, K.S. and Ghebre-Sellasie, I., Current Perspectives on the dissolution stability of solid oral dosage forms. J. Pharm. Sci., 82 (1993) 113-125.
16. Neuvonen, P.J., Pentikainen, P.J. and Elfving, S.M., Factors affecting the bioavailability of phenytoin. Int. J. Clin. Pharmacol., 15 (1977) 84-89.
17. Nishikido, N., Moroi, Y., Uehara, H. and Matuura, R., Effect of alcohols on the micelle formation of non-ionic surfactants in aqueous solutions. Bull. Chem. Soc. Japan, 47 (1974) 2634-2638.
18. Pandit, N.K., Strykowski, J.M., Mcnally, E.J. and Waldbillig, A.M., Surfactant solutions as media for dissolution testing of a poorly water-soluble drug. Drug Dev. Ind. Pharm., 11 (1985) 1797-1818.
19. Parrot, E. and Sharma, V., Dissolution Kinetics of benzoic acid in high concentrations of surface-active agents. J. Pharm. Sci., 56 (1967) 1341-1343.
20. Philip, J., Holcomb, I.J. and Fusari, S.A., Phenytion. In: Flory, K. (Ed.), Analytical Profiles of Drug Substances, vol. 13, Academic Press, Orlando, FL, 1984, pp. 417-445.
21. Rubino, J.T., Halterlein, L.M. and Blanchard, J., The effects of aging on the dissolution of phenytoin sodium capsule formulations. Int. J. Pharm., 26 (1985) 165-174.
22. SAS/Stat User's Guide (Release 6.03), SAS Institute, Inc., Cary, North Carolina, 1988.
23. Serajuddin, T.A.M. and Jarowski, C.I., Influence of pH on release rate of phenytoin sodium from slow-release dosage forms. J. Pharm. Sci., 82 (1993) 306-310.
24. Shah, V.P., Prasad, V.K., Alston, T., Cabana, B.E., Gural, R.P. and Meyer, M.C., Phenytoin I: In-vitro - in-vivo correlation for 100 mg phenytoin sodium capsules. J. Pharm. Sci. 72 (1983) 306-308.
25. Stavchansky, S. and Gowan, W.G., Evaluation of the bioavailability of a solid dispersion of phenytoin in polyethylene glycol 6000 and a commercial phenytoin sodium capsule in the dog. J. Pharm. Sci., 73 (1984) 733-736.
26. Sved, S., Hossie, R.D., McGilvery, I.J., Beaudoin, N. and Brien, R., Bioavailability, Absorption and dissolution kinetics of phenytoin formulations. Can. J. Pharm. Sci., 14 (1979) 67-71.
27. USP 23-NF 18, 1995, 12601 Twinbrook parkway, Rockville, MD 20852.
28. Walkling, W.D., Nayak, R.K., Plostnieks, J. and Cressman, W.A., A partially organic dissolution medium for griseofulvin dosage forms. Drug Dev. Ind. Pharm., 5 (1979) 17-27.
29. Yakou, S., Yamazaki, S., Sonobe, T., Sugihara, M., Fakumuro, K. and Nagai, T., Particle size distribution affects the human bioavailability of phenytoin. Chem. Pharm. Bull., 34 (1986) 4400-4402.